Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
46.75T | 45.10T | 37.15T | 31.38T | 27.21T | 29.93T | Gross Profit |
9.50T | 9.37T | 6.31T | 5.97T | 4.83T | 5.41T | EBIT |
4.79T | 5.35T | 3.67T | 3.00T | 2.96T | 2.44T | EBITDA |
8.62T | 8.39T | 5.19T | 4.82T | 4.61T | 4.13T | Net Income Common Stockholders |
5.10T | 4.94T | 2.45T | 2.85T | 2.25T | 2.04T |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
13.88T | 14.11T | 9.23T | 8.62T | 9.32T | 5.70T | Total Assets |
94.67T | 90.11T | 74.30T | 67.69T | 62.27T | 52.68T | Total Debt |
39.58T | 36.56T | 29.38T | 26.50T | 25.66T | 20.55T | Net Debt |
31.29T | 27.15T | 21.86T | 20.38T | 20.56T | 16.36T | Total Liabilities |
57.82T | 54.87T | 45.04T | 40.53T | 37.98T | 31.94T | Stockholders Equity |
35.91T | 34.22T | 28.34T | 26.25T | 23.40T | 20.06T |
Cash Flow | Free Cash Flow | ||||
-1.60T | -842.02B | -750.76B | -107.63B | -1.04T | -4.49B | Operating Cash Flow |
4.24T | 4.21T | 2.96T | 3.72T | 2.73T | 3.59T | Investing Cash Flow |
-4.29T | -5.00T | -1.60T | -577.50B | -4.68T | -3.15T | Financing Cash Flow |
391.01B | 2.50T | -56.18B | -2.47T | 2.74T | 397.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $29.84B | 27.96 | 12.22% | ― | 10.28% | -29.75% | |
77 Outperform | $40.16B | 8.09 | 11.47% | 7.31% | 3.03% | 28.54% | |
75 Outperform | $238.78B | 7.82 | 13.36% | 3.12% | -0.59% | 7.56% | |
75 Outperform | $45.43B | 6.81 | 8.88% | 1.01% | 7.76% | -14.17% | |
74 Outperform | $46.67B | 8.30 | 6.54% | 4.13% | 4.37% | 6.93% | |
71 Outperform | $949.32B | 162.31 | 9.16% | ― | 1.03% | -53.71% | |
62 Neutral | $6.88B | 11.32 | 2.95% | 3.87% | 2.70% | -24.57% |